EAPH Income Statement

Easton Pharmaceuticals Inc. (EAPH)

Income Statement

Get Income Statement for:

View: Annual Data | Quarterly Data

All numbers in thousands

Period Ending		Sep 30, 2015	Jun 30, 2015	Mar 31, 2015	Dec 31, 2014
Total Revenue		–	–	–	67
Cost of Revenue		–	–	–	44

Gross Profit		–	–	–	24

	Operating Expenses
	Research Development	45	26	93	104
	Selling General and Administrative	371	48	28	57
	Non Recurring	–	–	–	–
	Others	–	–	–	–

	Total Operating Expenses	–	–	–	–


Operating Income or Loss		(416)	(74)	(121)	(137)

	Income from Continuing Operations
	Total Other Income/Expenses Net	19	2	40	89
	Earnings Before Interest And Taxes	(397)	(71)	(81)	(48)
	Interest Expense	–	–	–	–
	Income Before Tax	(397)	(71)	(81)	(48)
	Income Tax Expense	–	–	–	–
	Minority Interest	–	–	–	–

	Net Income From Continuing Ops	(397)	(71)	(81)	(48)

	Non-recurring Events
	Discontinued Operations	–	–	–	–
	Extraordinary Items	–	–	–	–
	Effect Of Accounting Changes	–	–	–	–
	Other Items	–	–	–	–


Net Income		(397)	(71)	(81)	(48)
Preferred Stock And Other Adjustments		–	–	–	–

Net Income Applicable To Common Shares		(397)	(71)	(81)	(48)

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com